Employer profile
Genprex
1 certified H-1B filings across 1 fiscal year.
FY2022 filings
1
FY2022 median
$155k
Top role
Associate Director, Formulations & Analytical Development
1 filings
Top state
TN
1 filings
Genprex has filed 1 certified H-1B Labor Condition Applications over FY2022. In FY2022, its median certified base salary was $155k ($155k–$155k interquartile range). The most-filed role is Associate Director, Formulations & Analytical Development (1 filings).
Year-over-year
How Genprex hired across H-1B fiscal years. The small figure under each filings count is its change vs the prior FY.
| FY | Filings | Median $ |
|---|---|---|
| FY2022 | 1— | $155k |
Top job titles
Most-filed positions, across all years (raw DOL titles).
| Job Title | Filings | Median |
|---|---|---|
| Associate Director, Formulations & Analytical Development | 1 | $155k |
Top worksite states
Where this employer files.
| State | Filings | Median |
|---|---|---|
| TN | 1 | $155k |
Prevailing wage level distribution
DOL Levels I–IV approximate experience tiers (I = entry, IV = fully competent). A heavy Level I/II skew suggests entry-level / contractor-style hiring; a heavy IV skew suggests senior in-house roles.
Lvl III
1100%
Frequently asked questions
- Does Genprex sponsor H-1B visas?
- Yes. Genprex has filed 1 certified H-1B Labor Condition Applications (LCAs) over FY2022. An LCA is a required step before an employer files an H-1B petition; a certified LCA does not by itself guarantee an approved visa.
- What is the median H-1B salary at Genprex?
- In FY2022, the median certified H-1B base salary at Genprex was $155k, with a 25th–75th percentile range of $155k–$155k. This is the annual base wage stated on the LCA and excludes bonus, equity, and other compensation.
- What jobs does Genprex hire H-1B workers for?
- Genprex's most-filed H-1B role is Associate Director, Formulations & Analytical Development (1 filings). Its top worksite state is TN.
- How many H-1B filings did Genprex submit in FY2022?
- Genprex had 1 certified H-1B LCA filings in FY2022.